Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion type Assertion NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_head.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion description "[We studied 109 malignant mesotheliomas (58 epithelioid, 26 sarcomatoid, and 25 biphasic) by immunohistochemistry and qRT-PCR analysis, and demonstrated a substantial switch from epithelial markers (E-cadherin, ?-catenin, and cytokeratins 5/6) to mesenchymal markers (N-cadherin, vimentin, ?-smooth muscle actin, Snail, Slug, Twist, ZEB1, ZEB2, S100A4, MMP2, and MMP9) through epithelioid to biphasic and sarcomatoid histotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_provenance.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion evidence source_evidence_literature NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_provenance.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion SIO_000772 21983934 NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_provenance.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion wasDerivedFrom befree-2016 NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_provenance.
- NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_assertion wasGeneratedBy ECO_0000203 NP929561.RABhw0q9MBB75_GJUIvDTG_wtP2EGyoyFd6wrwEK5IPgE130_provenance.